{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:57:20Z","timestamp":1791518240924,"version":"4.3.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":93,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02566","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T01:23:30Z","timestamp":1775438610000},"page":"e02566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Probable Loa loa-associated encephalopathy following ivermectin administration in a patient with malaria infection: A case report from the Democratic Republic of the Congo"],"prefix":"10.1016","volume":"44","author":[{"given":"Charles Malisaba","family":"Posite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Kasongo","family":"Findama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo\u00efse Kambale","family":"Vwiravwahali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Muhindo","family":"Molo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6368-7127","authenticated-orcid":false,"given":"Gabriel Kambale","family":"Bunduki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2026.e02566_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4269\/ajtmh.17-0664","article-title":"Case report: probable case of spontaneous encephalopathy due to loiasis and dramatic reduction of loa loa microfilariaemia with prolonged repeated courses of albendazole","volume":"99","author":"Arrey-Agbor","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idcr.2026.e02566_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1756-3305-6-283","article-title":"Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon","volume":"6","author":"Kouam","year":"2013","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.idcr.2026.e02566_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2883-2-S1-S7","article-title":"Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future","volume":"2","author":"Twum-Danso","year":"2003","journal-title":"Filaria J"},{"key":"10.1016\/j.idcr.2026.e02566_bib4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4269\/ajtmh.2008.78.546","article-title":"Case report: encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp","volume":"78","author":"Kamgno","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idcr.2026.e02566_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/1756-3305-7-307","article-title":"Innovative tools for assessing risks for severe adverse events in areas of overlapping Loa loa and other filarial distributions: the application of micro-stratification mapping","volume":"7","author":"Kelly-Hope","year":"2014","journal-title":"Parasit Vectors"},{"issue":"S1","key":"10.1016\/j.idcr.2026.e02566_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2883-2-S1-S3","article-title":"Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases","volume":"2","author":"Twum-Danso","year":"2003","journal-title":"Filaria J"},{"key":"10.1016\/j.idcr.2026.e02566_bib7","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/S1473-3099(23)00438-3","article-title":"The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasis","volume":"24","author":"Ramharter","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02566_bib8","first-page":"202","article-title":"MM. Post-ivermectin encephalopathy in Senegal: a case report","volume":"27","author":"Mansare","year":"2017","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.idcr.2026.e02566_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40801-017-0110-0","article-title":"Central and peripheral nervous system disorders following ivermectin mass administration: a descriptive study based on the Democratic Republic of Congo pharmacovigilance system","volume":"4","author":"Nzolo","year":"2017","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.idcr.2026.e02566_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4269\/ajtmh.13-0189","article-title":"Short report: absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events","volume":"90","author":"Fokom-Domgue","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idcr.2026.e02566_bib11","unstructured":"UNDP, World Bank, World Health Organization. Guidelines for rapid assessment of Loa loa. 2002."},{"key":"10.1016\/j.idcr.2026.e02566_bib12","unstructured":"World Health Organization. GONE webinar report, 4 December 2025. Loiasis: a very neglected diseases in Central Africa. 2025."}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092600079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092600079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:46:17Z","timestamp":1780991177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221425092600079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":12,"alternative-id":["S221425092600079X"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02566","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probable Loa loa-associated encephalopathy following ivermectin administration in a patient with malaria infection: A case report from the Democratic Republic of the Congo","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02566"}}